Researchers specializing in infectious disease at the University of Saskatchewan in Canada are turning to cannabis as they build a new COVID-19 virus vaccine candidate. The research team says that a plant-based antigen may be easier to produce commercially on a broad scale than animal-based antigens.

Read the full article